Brief: NRx Pharmaceuticals Announces Closing Of $6.28 Mln Registered Direct Offering
09/06/2023 13:47
June 9 (Reuters) - NRX Pharmaceuticals Inc NRXP.O :
* NRX PHARMACEUTICALS ANNOUNCES CLOSING OF $6.28 MILLION
REGISTERED DIRECT OFFERING
Source text for Eikon: ID:nPntZDGDa
Further company coverage: NRXP.O
((reuters.briefs@thomsonreuters.com;))
Recent news on NRX Pharmaceuticals
See all newsBrief: NRx Pharmaceuticals Reschedules Conference Call To Discuss Third Quarter And Year To Date 2024 Financial Results To November 18, 2024
U.S. RESEARCH ROUNDUP-Cintas Corp, Sprouts Farmers market, Voya Financial
U.S. STOCKS ON THE MOVE-Molson Coors, Starbucks, Warner Bros Discovery
U.S. STOCKS ON THE MOVE-Zebra Technologies, Ecolab, American Electric Power
NRX Pharmaceuticals Inc expected to post a loss of 7 cents a share - Earnings Preview